Home > iPhone > Attorney General James Launches Rulemaking Process to Combat Illegal Price Gouging and Corporate Greed

Attorney General James Launches Rulemaking Process to Combat Illegal Price Gouging and Corporate Greed

OAG Starts First Price Gouging Rulemaking Process asMajor Corporations Continue to Raise Consumer Prices

AG James Seeks Public Comments to Inform New Price Gouging Rules

NEW YORK – New York Attorney General Letitia James today launched a rulemaking process to look into whether major corporations are using the pandemic and inflation as an excuse to unfairly raise the price of basic goods. The first-ever price gouging rulemaking process by the Office of the Attorney General (OAG) will examine and address new evidence that some of the recent price hikes by big corporations were driven by profit not increased costs. Through this process, Attorney General James aims to implement new price gouging rules that will crack down on pandemic profiteering and corporate greed.

“The rising costs of essentials and basic household items has had a real impact on working families,” saidAttorney General James.“Throughout the pandemic, hardworking New Yorkers have been struggling to make ends meet, but big corporations have been celebrating record breaking profits. It doesn’t add up. My office is prepared to use every tool in our toolbox to crack down on price gouging and pandemic profiteering.”

New York’s price gouging law bans companies from taking advantage of a crisis to charge excessive prices for vital and necessary goods and services. The rulemaking process will explore growing evidence that big corporations appear to have used the pandemic as an excuse to charge more for necessary goods, such as gas and oil, food, and cars. As evidenced by the recent spike in corporate profits, many companies are not sharing in the burden of the pandemic, nor are they neutral. Evidence indicates that some companies are profiting by increasing costs for the people hit hardest by the pandemic.

Since the start of the pandemic, public reporting has highlighted instances of major corporations steadily increasing costs of goods onto consumers, despite experiencing record high revenue. Some examples of those reports include:

While not all of these may be illegal, some of them may fit the definition of price gouging under New York law.

Attorney General James Launches Rulemaking Process to Combat Illegal Price Gouging and Corporate Greed

New York’s law bans “unconscionably excessive” prices, which include both “unconscionably extreme” prices and prices set through “unfair leverage or unconscionable means.” New York’s statute is also unique in the wide scope of covered goods and services, and the fact that it covers all actors in the supply chain for those goods and services, including manufacturers, retailers, distributors, shipping firms, and online platforms. The law also prohibits price gouging not just of consumers but also small businesses and state and local governments.

The Advance Notice of Proposed Rulemaking (ANPR) outlines the evidence that some of the price increases for vital and necessary goods may violate New York law and lays out the incentive structures that can lead to price gouging. The ANPR also discusses the unique harms caused by price gouging and the economic justification for prohibiting this form of profiteering. The ANPR has been submitted to the State Register for publication and will be officially available on or about March 9.

The OAG is seeking comment from the public on a wide range of questions about price gouging, including questions about industry tools that may obscure price gouging.

Public comments in response to the ANPR may be submitted immediately and until April 22, 2022 at stopillegalprofiteering@ag.ny.gov.

Requesting public comments is part of the three-step process. Once public comments are submitted OAG will review them then propose new rules. Afterwards, the public will have 60 days to submit comments on the proposed rules. Following the 60 days, OAG will promulgate new price gouging rules.

This is the first rulemaking initiated under the 2020 amendments to New York’s General Business Law 396-r, which expanded the scope of the price gouging statute, and granted the Attorney General rulemaking authority.

“It’s unconscionable that corporations are using the COVID-19 pandemic as pretext for jacking up prices while so many New Yorkers are struggling,” saidState Senator Brad Holyman. “I’m glad to have passed legislation in 2020 to strengthen our price gouging statute and now work with Attorney General James to understand the scope of this costly problem and take additional steps to protect New York consumers through the rulemaking process.”

“Price gouging or profiteering during a time of crisis is simply unacceptable. We must do everything we can to prevent unethical profiteering and stop large companies from putting profit above the lives of people,” saidState Senator Kevin Thomas. “I commend Attorney General James for taking a stand against price gouging and corporate greed, diligently looking out for consumers, and ensuring that bad actors cannot use the pandemic to enrich themselves at New Yorkers’ expense.”

“As we work to protect New Yorkers from price gouging and predatory sales tactics, I encourage consumers and retailers alike to share their experiences,” saidAssemblymember Nily Rozic. “I'm thankful for Attorney General James' partnership in this effort to protect New Yorkers from illegal price gouging.”

This matter is being handled by Special Advisor and Senior Counsel for Economic Justice Zephyr Teachout of the Division of Economic Justice with support from Jane M. Azia and Jack Figura of the Consumer Frauds & Protection Bureau, Elinor R. Hoffmann and Michael Jo of the Antitrust Bureau, and Anisha Dasgupta of the Division of Appeals and Opinions. The Division of Economic Justice is led by Chief Deputy Attorney General Chris D’Angelo and overseen by First Deputy Attorney General Jennifer Levy.

Prev: Volkswagen Virtus Makes Global Debut In India Ahead Of Launch

Next: Lilly's Retevmo nodded as Korea's 1st RET kinase inhibitor < Pharma < 기사본문 - KBR